13FPulse
BB

BBIO BRIDGEBIO PHARMA INC

2026Q2 · CUSIP 10806X102 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
462
Institutions that reported holding it to the SEC
Net increase in holders
+7
Last quarter 455 → now 462
How unusual is that
Above average
Stronger buying than 62% of US stocks
What the filings say, in one paragraph

462 funds held BBIO at the end of 2026Q2, up 7 from the quarter before. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $713M(YoY +202.4%). BBIO has had 16 buying rushes in its history, and the price moved +24.8% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q3: holders=73 2019Q4: holders=85 2020Q1: holders=93 2020Q2: holders=113 2020Q3: holders=128 2020Q4: holders=160 2021Q1: holders=196 2021Q2: holders=197 2021Q3: holders=208 2021Q4: holders=191 2022Q1: holders=176 2022Q2: holders=161 2022Q3: holders=178 2022Q4: holders=177 2023Q1: holders=209 2023Q2: holders=196 2023Q3: holders=218 2023Q4: holders=246 2024Q1: holders=243 2024Q2: holders=251 2024Q3: holders=253 2024Q4: holders=263 2025Q1: holders=302 2025Q2: holders=358 2025Q3: holders=391 2025Q4: holders=431 2026Q1: holders=455 2026Q2: holders=462 -56 -28 +0 +28 +56 65276486 19Q320Q221Q121Q422Q323Q224Q124Q425Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 16 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20%
2025Q4 Top 20% -3.5%
2025Q3 Top 10% +5.7% +2.0%
2025Q2 Top 5% +35.4% +50.8%
2025Q1 Top 5% +45.2% +98.6%
2023Q4 Top 20% -19.1% -32.4%
2023Q3 Top 10% +24.6% +2.3%
2023Q1 Top 5% +101.8% +109.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
222
Change in large funds
+23
Total value they hold
$14.6B
Funds buying for the first time
85
Funds that sold out entirely
78
Price change that quarter
+17.1%
Funds holding puts (bearish)
15
Funds holding calls (bullish)
22

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-3.57
EPS YoY
Revenue (TTM)
$0.7B
Revenue YoY
+202.4%
Net margin
-98.5%
ROE
Debt ratio
FCF (TTM)
-$435M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -1.06 2021-12-31: EPS -1.00 2022-03-31: EPS -1.35 2022-06-30: EPS -0.07 2022-09-30: EPS -0.93 2022-12-31: EPS -0.91 2023-03-31: EPS -0.92 2023-06-30: EPS -0.98 2023-09-30: EPS -1.08 2023-12-31: EPS -0.97 2024-03-31: EPS -0.20 2024-06-30: EPS -0.39 2024-09-30: EPS -0.86 2024-12-31: EPS -1.43 2025-03-31: EPS -0.88 2025-06-30: EPS -0.95 2025-09-30: EPS -0.95 2025-12-31: EPS -1.00 2026-03-31: EPS -0.84 2026-06-30: EPS -0.78 0M 122M 244M $M -1.57 -0.79 0.00 2019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-220M-73M75M 201820192020202120222023202420252026
Latest quarter $-197M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.